1 September 2023 - Swiss drug maker Novartis on Friday said it had sued the US Government in an attempt to halt the Medicare drug-price negotiation program, which includes its top-selling heart failure medicine Entresto.

The lawsuit, filed in federal court in New Jersey, is the first since the Biden administration on Tuesday released its list of 10 prescription medicines that will be subject to price negotiations by the Medicare health program, which covers 66 million people.

Read Reuters article